Jeff Frelick - 25 Jan 2023 Form 4 Insider Report for Bone Biologics Corp (BBLG)

Role
Chief Executive Officer
Signature
/s/ Jeffrey Frelick
Issuer symbol
BBLG
Transactions as of
25 Jan 2023
Net transactions value
$0
Form type
4
Filing time
08 Mar 2023, 05:20:27 UTC
Previous filing
28 Feb 2022
Next filing
05 Sep 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BBLG Employee Stock Option Award $0 +37,750 +37% $0.000000 140,140 25 Jan 2023 Common Stock 37,750 $0.2400 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.